Gufic Biosciences Limited

BSE:509079 Stock Report

Market Cap: ₹34.3b

Gufic Biosciences Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Pranav Choksi

Chief executive officer

₹4.4m

Total compensation

CEO salary percentage99.1%
CEO tenure20.8yrs
CEO ownership7.2%
Management average tenure6.4yrs
Board average tenure8.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Pranav Choksi's remuneration changed compared to Gufic Biosciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

₹820m

Sep 30 2024n/an/a

₹849m

Jun 30 2024n/an/a

₹864m

Mar 31 2024₹4m₹4m

₹861m

Dec 31 2023n/an/a

₹842m

Sep 30 2023n/an/a

₹823m

Jun 30 2023n/an/a

₹793m

Mar 31 2023₹2m₹2m

₹797m

Dec 31 2022n/an/a

₹819m

Sep 30 2022n/an/a

₹826m

Jun 30 2022n/an/a

₹857m

Mar 31 2022₹2m₹2m

₹958m

Dec 31 2021n/an/a

₹884m

Sep 30 2021n/an/a

₹829m

Jun 30 2021n/an/a

₹769m

Mar 31 2021₹6m₹2m

₹442m

Dec 31 2020n/an/a

₹305m

Sep 30 2020n/an/a

₹243m

Jun 30 2020n/an/a

₹123m

Mar 31 2020₹5m₹2m

₹227m

Dec 31 2019n/an/a

₹243m

Sep 30 2019n/an/a

₹232m

Jun 30 2019n/an/a

₹249m

Mar 31 2019₹2m₹2m

₹219m

Dec 31 2018n/an/a

₹164m

Sep 30 2018n/an/a

₹168m

Jun 30 2018n/an/a

₹164m

Mar 31 2018₹2m₹2m

₹165m

Compensation vs Market: Pranav's total compensation ($USD51.34K) is below average for companies of similar size in the Indian market ($USD289.82K).

Compensation vs Earnings: Pranav's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Pranav Choksi (41 yo)

20.8yrs

Tenure

₹4,432,332

Compensation

Mr. Pranav Jayesh Choksi has been an Executive Whole Time Director of Gufic Biosciences Ltd. since June 25, 2004 and serves as its Chief Executive Officer. Mr. Choksi serves as Chief Executive Officer & Wh...

Leadership Team

NamePositionTenureCompensationOwnership
Jayesh Choksi
Chairman & MD25.6yrs₹4.82m24.62%
₹ 8.4b
Pranav Choksi
CEO & Whole Time Directorno data₹4.43m7.25%
₹ 2.5b
Pankaj Gandhi
Whole-Time Directorno data₹1.74mno data
Devkinandan Roonghta
Chief Financial Officer6.4yrs₹2.96mno data
Nagesh Yarrabathina
Chief Operating Officerno datano datano data
Ami Shah
Company Secretary9yrs₹892.96kno data
Pinak Padhya
Associate Vice President - Sales & Marketingno datano datano data
Sunil Desai
Head – Human Resource Departmentno datano datano data
Ashok Dev
President of Operationno datano datano data
Shekhar Aley
Senior Vice President - Critical Care SBUsno datano datano data
Rasik Kulkarni
SVP - Ferticare & Ferticare Life & Aesthadermno datano datano data
Rajeev Agarwal
President of Ferticare1.1yrsno datano data

6.4yrs

Average Tenure

62yo

Average Age

Experienced Management: 509079's management team is seasoned and experienced (6.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jayesh Choksi
Chairman & MD25.6yrs₹4.82m24.62%
₹ 8.4b
Pranav Choksi
CEO & Whole Time Director20.8yrs₹4.43m7.25%
₹ 2.5b
Pankaj Gandhi
Whole-Time Director11.6yrs₹1.74mno data
Anu Aurora
Independent Director5.3yrs₹70.00kno data
Kamal Seth
Independent Directorless than a yearno datano data
Akshya Mahapatra
Non-Executive & Independent Directorless than a yearno datano data

8.4yrs

Average Tenure

65yo

Average Age

Experienced Board: 509079's board of directors are considered experienced (8.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/20 13:09
End of Day Share Price 2025/03/20 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Gufic Biosciences Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research
Naveed MD.FirstCall Research